Our Partners

Associate Partner - ActeaVentures

Global partners for Life Sciences Business Development 

http://www.acteaventures.com/

Consultant -  Links Consultants

Consulting, Interim Management, Training and Task Force
http://www.links-consultants.com/-Groupe-d-intervention,99-.html

PharmInsight AG

Life Sciences Business Developmebt in Europe, Asia, Pacific Region with focus on Russia and CIS, Japan and Korea 

http://www.pharm-insight.com/

Positive Capital

Financial Investment Advisor support for equity transactions: fund-raising, financial engineering, asset and business transfers, acquisitions, sales of subsidiaries, valuation.

http://www.positive-capital.com

Alliance Management - Bacarau

Collaborative Business Development 

http://www.bacarau.com/


 

 

 

http://www.acteaventures.com/

 

Madrid, Karlsruhe, San Francisco, Boston, Shangai, Singapore

 

ActeaVentures is a global business development firm with operations in the US, Europe and Asia. We offer our clients comprehensive services covering all aspects of dealmaking and partnering in the Life Science industry.

 

Our team consists of Senior BD&L professionals with a long track record of successful dealmaking and partnering both as employees in Senior positions in big pharma (Pfizer, Lilly, Roche, Bayer/Schering), biotech (Cardion, Onyx Pharmaceuticals, PharmaMar, Amgen), diagnostics (Roche), as well as in independent consultancy roles.


 

ActeaVentures unifies all this expertise into a dynamic team which is eager to make your licensing project a lasting success. 

 

 

 

 

 

http://www.links-consultants.com/

 

Paris, France

A consulting company with more than 300 consultants and networking with 1,000 consultants 

 

Assits companies with strategy definition and implementation taking care of the alignment between process and value creation objectives.

 

 

 Financial Investment Advisor register under the AMF, the french Financial Authority : ORIAS N° 13000720

 

 

Our mission: support the creation of value.

 

Our offer: the decision support and corporate finance operations.

 

Positive Capital offers support for equity transactions: disposals, fund-raising, financial engineering, asset and business transfers, acquisitions, sales of subsidiaries, valuation.

 

Our customers are entrepreneurs, shareholders and investors wishing to support leading entrepreneurs and companies, paving the way for a better and sustainable world.

 

With more than thirty deals completed over the past five years, every transaction is closely managed to ensure that the client’s objectives are fully met.

Professional liability : ZURICH INSURANCE plc.

 

 

Positive capital  http://www.positive-capital.com/

 

 

 

 

 

 

 

 

http://www.bacarau.com/

 

Paris, France

 

Collaborative Business Development 

Notre métier est d’assurer que les collaborations extérieures de l’entreprise soient rentables, pérennes et sécurisées grâce à la mise en œuvre de savoir-faire formalisés par l'Association of Strategic Alliance Professionals, première et plus importante organisation professionnelle internationale dédiée au développement des entreprises par la formation d'Alliances / Partenariats.

 

PharmaBioDev

http://www.pharmbiodev.com/

 

PharmBioDev is a global consultancy specialised in drugs and biologicals development. PharmBioDev offers a complete range of services spanning from Development to Marketing activities:

- Development covers preclinical and clinical development until regulatory registration

- Due diligence: supporting you in all aspects of scientific and medical due diligence

- Scientific communication: Developing a scientific communication plan with your key opinion leaders.

 

 

 

 

 

http://www.panacee.fr 

  

Lyon, France

 

French communication agency: 

As a global communication agency, we consider the phase of reflection and analysis as essential to aim at strategic and graphic coherence.

 

Our value. Recognizing the singularity of the life sciences market. We have a wide experience of the codes and specific approaches linked to the inherent features of our targets - researchers, academics, scientists, practitioners, industrialists, patients.